SN.L - Smith & Nephew plc

LSE - LSE Delayed price. Currency in GBp
1,392.50
+16.50 (+1.20%)
As of 8:51AM BST. Market open.
Stock chart is not supported by your current browser
Previous close1,376.00
Open1,384.00
Bid1,392.00 x 240300
Ask1,392.50 x 53000
Day's range1,384.00 - 1,393.00
52-week range1,173.00 - 1,442.00
Volume152,722
Avg. volume3,785,924
Market cap12.173B
Beta0.25
PE ratio (TTM)15.88
EPS (TTM)87.70
Earnings date8 Feb 2018 - 13 Feb 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.48
  • Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.20 days ago

    Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?

    The size of Smith & Nephew plc (LSE:SN.), a UK£11.91B large-cap, often attracts investors seeking a reliable investment in the stock market. Big corporations are much sought after by risk-averseRead More...

  • 2 FTSE 100 stocks I’d buy in June
    Fool.co.uk21 days ago

    2 FTSE 100 stocks I’d buy in June

    These two FTSE 100 (INDEXFTSE:UKX) stocks have outstanding long-term growth prospects, says G A Chester.

  • Reuters - UK Focus2 months ago

    BUZZ-Top of the Street: BBVA, Standard Life Aberdeen, Commerzbank

    A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** "Too cheap to ignore," UBS says about BBVA and ups the bank to "buy", also pointing to earnings ...

  • Reuters - UK Focus2 months ago

    Smith & Nephew, financials knock FTSE off 3-month high

    Britain's top share index slipped on Thursday as a tumble in Smith & Nephew's shares and weakness across financials and health stocks dragged the FTSE 100 off a three-month high. Despite a firmer start to trading and a weaker pound, the blue chip FTSE 100 turned lower and ended the session down 0.54 percent at 7,502.69 points, only slightly outperforming a negative European market.

  • Why the flu season has helped leave Smith & Nephew feeling cold
    Sky News2 months ago

    Why the flu season has helped leave Smith & Nephew feeling cold

    With (Other OTC: WWTH - news) the population ageing in most rich countries round the world, these should in theory be bumper times for Smith & Nephew (Frankfurt: 502816 - news) , Europe's largest maker of artificial knees, shoulders and hips. It's a disappointing last trading update for Olivier Bohuon, who steps down as chief executive on Monday, although in his defence, the Frenchman - a pharmacy graduate - can point out that he has doubled the share price since he took the job in 2011. One is that Smith & Nephew is seeing weakness in a product area for which it is slightly less well-known - advanced wound management, which supplies ointments, bandages and dressings to healthcare suppliers.

  • MarketWatch2 months ago

    FTSE 100 breaks 5-day win streak as investors weigh Fed’s next move

    U.K. stocks dropped Thursday, following a five-session winning streak for the blue-chip market, with the focus on the U.S. Federal Reserve decision and its flagging of stronger inflation. Stocks were little changed after a reading on British services activity missed expectations. Shares of Smith & Nephew posted the biggest loss in London after a revenue warning.

  • European shares retreat as trade worries weigh on Wall Street
    Reuters2 months ago

    European shares retreat as trade worries weigh on Wall Street

    By Danilo Masoni and Julien Ponthus MILAN/LONDON (Reuters) - European bourses closed in negative territory on Thursday at the end of a session laden with corporate earnings and as worries over global trade ...

  • I’d happily buy FTSE 100 stock Smith & Nephew despite this chilling news
    Fool.co.uk2 months ago

    I’d happily buy FTSE 100 stock Smith & Nephew despite this chilling news

    Royston Wild explains why Smith & Nephew plc (LON: SN) remains a white-hot FTSE 100 (INDEXFTSE: UKX) growth stock.

  • Reuters - UK Focus2 months ago

    GLOBAL MARKETS-Trade worries keep world stocks subdued, dollar holds gains

    World stocks made little progress on Thursday as worries over global trade tensions weighed, while the U.S. dollar consolidated recent bumper gains after the Federal Reserve reaffirmed the outlook for more rate hikes. Europe's pan-European STOXX 600 index was down 0.3 percent as the euro held firm. In Europe, earnings disappointments from medical technology company Smith & Nephew (Frankfurt: 502816 - news) and postal services provider Bpost (EUREX: BPO.EX - news) soured the mood as the stocks fell 6.3 percent and 10.5 percent respectively, while German drug and crop chemicals maker Bayer (IOB: 0P6S.IL - news) flagged a stronger euro in its update.

  • Reuters - UK Focus2 months ago

    LIVE MARKETS-FTSE out of the red as weak data hits pound again

    Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Danilo Masoni. Reach him on Messenger to share your thoughts on market ...

  • Reuters - UK Focus2 months ago

    Commodities help Britain's FTSE outperform while Smith & Nephew tumbles

    A strong outlook from miner Glencore and gains in oil stocks provided the bedrock for British shares to outperform stock markets on the continent on Thursday. Mining and energy stocks helped the FTSE stay ...

  • Reuters2 months ago

    Outgoing Smith & Nephew CEO signs off with a downgrade

    Smith & Nephew downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted. Bohuon, who steps down on Monday, said the business had seen a "mixed performance" in the quarter to end-March, with established markets like the United States and Europe down 2 percent on an underlying basis and emerging markets up 9 percent, resulting in a flat result overall.

  • Reuters - UK Focus2 months ago

    Outgoing Smith & Nephew CEO signs off with a downgrade

    Smith & Nephew (Frankfurt: 502816 - news) downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted.

  • Reuters - UK Focus2 months ago

    European shares dip on heavy earnings day as euro rebounds

    European bourses fell in morning trading on Thursday, weighed down by a rebound in the euro and a series of disappointing earning updates including from Smith & Nephew. The pan-European STOXX 600 index ...

  • Reuters - UK Focus2 months ago

    BUZZ-Smith & Nephew: guidance cut spurs worst day in 9 years

    ** Europe's biggest artificial hip and knee maker slumps 6.1 pct, biggest one-day drop since March 2009 ** Co cuts forecast for 2018 underlying revenue growth and profit margin after some markets softened ...

  • Reuters - UK Focus2 months ago

    Smith & Nephew downgrades outlook after weak Q1

    Smith & Nephew, Europe's biggest artificial hip and knee maker, downgraded its forecast for full-year underlying revenue growth and profit margin after some markets softened and it saw a slowdown in its ...

  • The Wall Street Journal2 months ago

    [$$] WPP Chairman Looks to Fill the Gap Left by Sorrell’s Sudden Exit

    A little known private-equity executive will steer WPP PLC through one of its stormiest periods following the resignation last weekend of Martin Sorrell.

  • Reuters - UK Focus3 months ago

    LIVE MARKETS-Move into defensives paying off

    Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...

  • Reuters - UK Focus3 months ago

    LIVE MARKETS-Mid-session snapshot: STOXX at lows

    Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...

  • Reuters - UK Focus3 months ago

    LIVE MARKETS-Tariffs on U.S. aircraft hit Boeing, boost Airbus

    Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...

  • Reuters - UK Focus3 months ago

    LIVE MARKETS-Trade wars: what's the damage?

    Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market ...

  • Reuters3 months ago

    Smith & Nephew picks new CEO who sold his last company

    Artificial hip and knee maker Smith & Nephew (SN.L), a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making. Namal Nawana, who will replace Olivier Bohuon as CEO of the British company next month, most recently headed medical diagnostics firm Alere, where he oversaw its $5.3 billion sale to Abbott (ABT.N) in 2017. The medical technology firm, which also has wound-care and sports medicine units, is under pressure to improve margins and find new sources of growth as it competes with bigger rivals.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes